Skip to main content
. Author manuscript; available in PMC: 2015 Dec 30.
Published in final edited form as: J Pharmacol Exp Ther. 2012 Apr 4;342(1):81–90. doi: 10.1124/jpet.112.194142

Fig. 3.

Fig. 3

Inhibition of PQ-induced myofibroblast transformation by Res. WI38-VA13 cells were treated with PQ (10 µM), Res (10 µM), or PQ + Res (pretreated for 16 h) for 24 h. Immunostaining was performed with an anti-αSMA antibody followed by Alex 549-conjugated second antibody (red). A, images were taking by confocal microscopy. The nucleus was counterstained with DAPI (blue). Bars, 20 nm. B, quantification of the images taken from five representative separate fields. **, p < 0.01; ***, p < 0.001.